Skip to main content

Personal genetics company 23andme is taking it further

The personal genetics start up company 23andme is taking a step further in getting into peoples mind. After advertising on web space through its parent company Google(One of the investor in this company is wife of Google's co-owner), its now looking into new avenues to get the word out to the public to get their genes tested for disease risks.

One can only imagine the extent of competition in this growing field of personal genetics. As a population geneticist, working for one of the molecular biology companies, I can see so many companies coming up in no time that are investing in personal genetics. Some of them made good impression, while others have not lasted long like Geneessence. One of the new ones being Pathway Genomics. Now other successful or atleast in the business being Navigenics and decodeme. Knome is another start up that looks into more details than the other ones mentioned earlier.



Well, there are many coming up and I will let you know one that is coming up in south, probably the first one. I will have to talk about it in future, few months from now. For now, 23andme is the prime interest as its Google owned or partly owned company that is trying to get into people like Google site. However, its a different ball game here as its life sciences and there are many amazing people in this world who knows more than the people at 23andme. So, to cope up with the growing competition and sprouting personal genomics companies, they have to come up with some innovative ideas as this one that has made some interesting news today, as written by none other than Michael Arrington of TechCrunch.

I hope that this stunt would help 23andm3 to get the attention it needs to make itself a better "bioinformatics service" and need no license to operate in California. Obviously only a better service and unambiguous results can help get more people get their genome tested for their risks of prominent diseases. Until then, we need to be cautious in predicting the results and making life changing decisions as the results are not always correct and dependable, as mentioned by Dave Rigotti "I’ve spoken with a geneticist (PhD from Harvard) about 23andMe and the information the tests provided. He said, in short, that the data is pretty much useless to an individual and that most factors contributing to a disease are environmental. However, he said that on a very large scale the mapping of the genes could provide valuable research."

One should not just spend money on these tests to know their risks, but should spend time exercising. May be one needs to spend that money on gym to get fit than just knowing the risks and worrying about it.
Labels:

Comments

Post a Comment

Popular posts from this blog

Butterfly effect and autism spectrum disorder

A study conducted by researchers at the RIKEN Center for Brain Science (CBS) has shed light on the genetics of Autism Spectrum Disorder (ASD). They found that a particular type of genetic mutation contributes to ASD differently than typical mutations. By analyzing mutations in the genomes of individuals and their families, the researchers discovered that the three-dimensional structure of the genome can cause mutations to affect neighboring genes associated with ASD, even without mutations in ASD-related genes. The study was published in the scientific journal Cell Genomics on January 26. ASD is a group of conditions characterized by repetitive behaviors and social interaction difficulties. Although the condition runs in families, its heritability is complex and only partially understood. According to studies, the high heritability cannot be explained by merely looking at the part of the genome responsible for protein coding. Instead, the answer could lie in the non-coding regions of t...
Read more

Charging Implanted Heart Pumps Wirelessly

Mechanical pumps to give failing hearts a boost were originally developed as temporary measures for patients awaiting a heart transplant. But as the technology has improved, these ventricular assist devices commonly operate in patients for years, including in former vice-president Dick Cheney, whose implant this month celebrates its one-year anniversary. Prolonged use, however, has its own problems. The power cord that protrudes through the patient's belly is cumbersome and prone to infection over time. Infections occur in close to 40 percent of patients, are the leading cause of rehospitalization, and can be fatal. Researchers at the University of Washington and the University of Pittsburgh Medical Center have tested a wireless power system for ventricular assist devices. They recently presented the work in Washington, D.C. at the American Society for Artificial Internal Organs annual meeting, where it received the Willem Kolff/Donald B. Olsen Award for most promising research in...
Post a Comment
Read more

Small Protein, Big Impact: Microprotein Discovery Offers Hope for Obesity and Aging

Researchers have uncovered a tiny but powerful protein that helps keep our cells’ energy factories humming – a discovery that could spark new approaches to tackling obesity and age-related decline. Scientists at the Salk Institute in La Jolla found that a  “microprotein”  in mouse fat cells plays a critical role in maintaining healthy  mitochondria , the structures that generate energy in our cells. By preserving mitochondrial function, this diminutive protein helps cells burn fuel efficiently, which in turn could influence body weight and the aging process. The findings shine light on how molecular biology connects to everyday health, opening the door to  science-backed strategies for better metabolism and longevity. Mature brown fat cells from a mouse, with the newly discovered microprotein shown in red inside mitochondria (green) and nuclei in blue. This tiny protein helps preserve mitochondrial health under stress. (Credit: Salk Institute) Mighty Mitochondria in ...
Read more